Intraoperative Evaluation of Sarcoma Surgical Margins With Indocyanine Green Fluorescence Imaging: Results From an Observational Study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessment of Surgical Margins in Sarcoma Procedures Using Indocyanine Green Fluorescence Imaging: Findings from an Observational Study

  • By

  • Sumail Bhogal

  • Matthew Gong

  • William Li

  • Brenda Diergaarde

  • Alma Heyl

  • Clark Roth

  • Lawrence Garvin

  • Alexander Hoffman

  • Amanda Locker

  • Ines Lohse

  • Maria Silvaggio

  • Stella Lee

  • Richard McGough

  • Kurt Weiss

  • September 17, 2026

Share

  • 1

    Sarcomas are rare malignancies, constituting about 1% of adult cancers and 7%-15% of pediatric cancers, with a high 5-year mortality rate.

  • 2

    Achieving negative surgical margins is crucial in sarcoma management, as positive margins are linked to local recurrence and increased mortality.

  • 3

    Indocyanine green (ICG) fluorescence imaging has shown effectiveness in achieving adequate margins in various cancers, including sarcomas.

  • 4

    The study evaluated ICG's utility in 51 sarcoma patients, establishing a new signal-to-background ratio protocol for detecting positive margins.

  • 5

    This research represents the largest report on ICG use in sarcoma surgery and suggests the need for a multicenter prospective clinical trial.

Original Source(s)

Intraoperative Evaluation of Sarcoma Surgical Margins With Indocyanine Green Fluorescence Imaging: Results From an Observational Study

  • by Sumail Bhogal, Matthew Gong, William Li, Brenda Diergaarde, Alma Heyl, Clark Roth, Lawrence Garvin, Alexander Hoffman, Amanda Locker, Ines Lohse, Maria Silvaggio, Stella Lee, Richard McGough, Kurt Weiss

  • September 17, 2026

Related Content

AI-Designed Binder Improves CAR T Cell Activity in Mice

Researchers screened 1,758 de novo protein binders and identified design features that influence CAR T cell activation, specificity, and tumor control

  • September 15, 2026

  • 3 min
The evolution of RTOG and NRG Oncology CNS tumors clinical trials

Retraction Note: Lycorine inhibits angiogenesis by docking to PDGFRα